Medical information inquiries and standard response documents for medical affairs AI

This page is general information, not legal advice. Confirm requirements with counsel for your jurisdiction and use case.

What a medical information inquiry record contains

A usable record is the full inquiry lifecycle from intake to closure, exported from the contact center's case system rather than reconstructed later. Medical information teams already treat medical information request (MIR) data as an analytics asset for safety signals and evidence gaps [8], and vendors describe medical information teams adopting AI for inquiry handling [10]. For model training, the fields that matter are the ones that show the specialist's decisions:

• Channel and requester type: phone, email, web form, live chat, field-forwarded; HCP specialty, pharmacist, patient, caregiver, payer.
• Verbatim question plus any clarifying exchange, in the original language.
• Product, indication and on-label or off-label determination at the time of the inquiry.
• Category and subcategory from the sponsor's taxonomy (dosing, interactions, stability and storage, pregnancy and lactation, off-label efficacy, formulation).
• SRD ID and version used, plus any custom response written when no SRD fit.
• Sent response text and attachments (reprints, prescribing information).
• AE and product quality complaint (PQC) flags, with the reconciliation status against the safety database.
• Timestamps for receipt, first response and closure.

Public alternatives exist but differ in kind. One open HCP Q&A release blends real-world and synthetic questions covering dosage, adverse reactions, interactions and off-label use [9]; that is useful for prototyping, but it lacks the sponsor-specific taxonomy, SRD linkage and safety routing that a production model has to reproduce.

Why off-label status has to travel with every record

The on-label or off-label determination is a training label in its own right, because the response rules change with it. FDA's December 2011 draft guidance on unsolicited requests separates public from non-public requests and recommends that private responses go only to the requester, answer only the question asked, be truthful, balanced and scientific, and come from medical or scientific staff rather than sales [1]; it was a draft, and later FDA draft guidance has proposed revising its approach to public requests. A separate January 2025 guidance covers firm-initiated sharing of scientific information on unapproved uses, and FDA's page has marked it as not for current implementation pending OMB review [2]. As of October 2026, check FDA's guidance search page for the current status of both before you design policy logic around either.

Three failure modes follow for a dataset:

1. Solicited and unsolicited inquiries mixed without a flag. A model trained on both learns to volunteer off-label content. Require a solicited field, or exclude anything forwarded by commercial staff.
2. Expanded scope in sent responses. If specialists sometimes answered beyond the question, the "gold" response teaches scope creep. Sample sent letters and grade scope adherence before you treat them as targets.
3. Label drift. An off-label question in 2021 may be on-label after a supplemental approval. Keep the label version date on each record so the model learns the determination as of the inquiry, not today.

Standard response documents are licensed content, not exhaust

SRDs are approved sponsor content, so the training right has to come from the manufacturer that owns them, not just the contact center vendor that hosts the inquiries. A medical information outsourcer may hold years of inquiry logs across several sponsors, but each sponsor's SRDs, response letters and taxonomy belong to that sponsor. The chain-of-title documents you request should show who authored the SRDs, who approved them and who can license them.

For retrieval and drafting, ask for the SRD library with version history, effective and retirement dates, and the references cited in each document. Retired SRDs are useful as negatives: a retriever that surfaces a withdrawn document is a compliance defect. RAFT-style fine-tuning, which trains on a question with the correct document plus distractors, maps well onto SRD libraries where several near-identical versions compete [11]. SRDs are also heavily templated, so run near-duplicate detection across versions and sent letters; duplicated text raises verbatim memorization [12].

Adverse event and complaint flags are the highest-value labels

Every inquiry is a potential safety intake, so the AE and PQC flags, and whether a human confirmed them, are the labels most buyers underprice. A patient asking whether a rash is related to a dose, or an HCP reporting that a pen injector jammed, must be routed to pharmacovigilance or complaint handling within the sponsor's SOP clock. Downstream, those cases become individual case safety reports structured under ICH E2B(R3) [3]; your data should at least carry the safety case ID and whether a case was opened, even if the case narrative itself is out of scope.

Ask for false-negative evidence, not just positives: inquiries later found by a reconciliation or audit to contain an unreported AE. That set is small, but it is the evaluation that matters for an AE-detection classifier. Device-related complaints overlap with the records on our medical device complaint and MDR decision page, and health-authority questions follow different rules covered on the health authority queries and sponsor responses page.

De-identifying inquirers and the patients they describe

Inquirer names, phone numbers, NPIs and institution names are personal data, and patient details inside a question need de-identification even when HIPAA does not reach the manufacturer. Many manufacturers are not HIPAA covered entities for their medical information function, but state law such as Washington's My Health My Data Act defines consumer health data broadly enough to cover a patient's own inquiry [6]. Where records are protected health information, de-identification follows Safe Harbor or Expert Determination [4] under 45 CFR 164.514 [5].

Free text is where methods fail: a rare-disease question naming a small town and a treatment date can identify a patient after every listed identifier is gone, and NIST documents re-identification of data believed de-identified [7]. Models can also emit memorized contact details verbatim [13]. Use the de-identification evidence package checklist and the PII redaction measurement guide to test recall on inquiry text, and treat call audio as a separate, higher-risk deliverable.

Request template for a medical information dataset

Illustrative example: invented to show structure; it does not describe an available dataset.

A single illustrative joined record might read: inquiry_id: MI-000481; channel: email; requester: pharmacist; product: [Product A]; label_status: off_label; solicited: true; category: stability/storage; srd_id: SRD-A-114 v3; ae_flag: false; pqc_flag: false; language: es.

How SourceX sources this data

SourceX sources operational datasets from US companies on request and manages the commercial process, including the license and ongoing purchases; nothing is held in stock and a request does not guarantee a match. You describe the data, such as inquiry logs with SRD linkage and AE flags, and SourceX looks for US businesses that hold it; every release is approved by the supplying company. Each dataset is rights-reviewed for ownership and consents, health records require HIPAA de-identification by Safe Harbor or Expert Determination, and names, emails, phones and account numbers are removed or replaced, with the method recorded and a sample checked, though no method is perfect. Delivery runs through private, access-controlled workflows only after an executed agreement. Buyers can describe a medical information dataset to SourceX at any stage of scoping.

Related reading: the industry-specific operational data guide, healthcare buyers, customer support ticket datasets for adjacent intake patterns, and knowledge base articles for retrieval corpora.

License medical information inquiry data for your model

SourceX serves AI teams wherever they are based and moves each request through Find, Assess, Agree, Transact and Manage, with pricing and allowed uses set in a license and nothing contracted until a supplier agrees. Diligence materials on source, rights, preparation and allowed use are prepared per dataset. Start a medical information data request.